Interleukin-15 and 21

The Cytokine Handbook

Volumn , Issue , 2003, Pages 431-463

  Shurin, Michael R ^a   Tourkova, Irina L ^a   Hackstein, Holger ^a,b   Shurin, Galina V ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33847036885     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50022-3     Document Type: Chapter

References (214)

1. Adunyah S.E., Wheeler B.J., Cooper R.S. Evidence for the involvement of LCK and MAP kinase (ERK-1) in the signal transduction mechanism of interleukin-15. Biochem. Biophys. Res. Commun. 1997, 232:754-758.
2. Agarwal R., Loganath A., Roy A.C., et al. Expression profiles of interleukin-15 in early and late gestational human placenta and in pre-eclamptic placenta. Mol. Hum. Reprod. 2001, 7:97-101.
3. Agostini C., Trentin L., Facco M., et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J. Immunol. 1996, 157:910-918.
4. Agostini C., Zambello R., Facco M., et al. CD8 T-cell infiltration in extravascular tissues of patients with human immunodeficiency virus infection. Interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction. Blood 1999, 93:1277-1286.
5. Ahmad A., Sharif-Askari E., Fawaz L., Menezes J. Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction. J. Virol. 2000, 74:7196-7203.
6. Ajjan R.A., Watson P.F., Weetman A.P. Detection of IL-12, IL-13, and IL-15 messenger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 1997, 82:666-669.
7. Allavena P., Giardina G., Bianchi G., Mantovani A. IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. J. Leukoc. Biol. 1997, 61:729-735.
8. Alleva D.G., Kaser S.B., Monroy M.A., et al. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J. Immunol. 1997, 159:2941-2951.
9. Ameglio F., D'Auria L., Cordiali-Fei P., et al. Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients with Pemphigus vulgaris relationships with peripheral blood neutrophil counts, disease severity and duration and patients' age. J. Biol. Regul. Homeost. Agents 1999, 13:220-224.
10. Anderson D.M., Johnson L., Glaccum M.B., et al. Chromosomal assignment and genomic structure of IL15. Genomics 1995, 25:701-706.
11. Anderson D.M., Kumaki S., Ahdieh M., et al. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 1995, 270:29862-29869.
12. Angiolillo A.L., Kanegane H., Sgadari C., et al. Interleukin-15 promotes angiogenesis in vivo. Biochem. Biophys. Res. Commun. 1997, 233:231-237.
13. Armitage R.J., Macduff B.M., Eisenman J., et al. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J. Immunol. 1995, 154:483-490.
14. Arnold R., Seifert M., Asadullah K., Volk H.D. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interactions, modulation by cytokines. J. Immunol. 1999, 162:7140-7147.
15. Asadullah K., Haeussler-Quade A., Gellrich S., et al. IL-15 and IL-16 overexpression in cutaneous T-cell lymphomas, stage-dependent increase in mycosis fungoides progression. Exp. Dermatol. 2000, 9:248-251.
16. Asao H., Okuyama C., Kumaki S., et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 2001, 167:1-5.
17. Azimi N., Brown K., Bamford R.N., et al. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site. Proc. Natl. Acad. Sci. USA 1998, 95:2452-2457.
18. Azimi N., Mariner J., Jacobson S., Waldmann T.A. How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy/tropical spastic paraparesis?. AIDS Res. Hum. Retroviruses. 2000, 16:1717-1722.
19. Azzarone B., Pottin-Clemenceau C., Krief P., et al. Are interleukin-2 and interleukin-15 tumor promoting factors for human non-hematopoietic cells?. Eur. Cytokine Network 1996, 7:27-36.
20. Baird A.M., Gerstein R.M., Berg L.J. The role of cytokine receptor signaling in lymphocyte development. Curr. Opin. Immunol. 1999, 11:157-166.
21. Bamford R.N., Grant A.J., Burton J.D., et al. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl Acad. Sci. USA 1994, 91:4940-4944.
22. Bamford R.N., Battiata A.P., Waldmann T.A. IL-15, the role of translational regulation in their expression. J. Leukoc. Biol. 1996, 59:476-480.
23. Barzegar C., Meazza R., Pereno R., et al. IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops. Oncogene 1998, 16:2503-2512.
24. Basok A., Shnaider A., Man L., et al. CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES. J. Am. Soc. Nephrol. 2001, 12:695-702.
25. Bassonga E., Forest V., Pierre F., et al. Cytokine mRNA expression in mouse colon, IL-15 mRNA is over-expressed and is highly sensitive to a fibre-like dietary component (short-chain fructo-oligosaccharides) in an Apc gene manner. Cytokine 2001, 14:243-246.
26. Bayard-McNeeley M., Doo H., He S., et al. Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro. Clin. Diagn. Lab. Immunol. 1996, 3:547-553.
27. Blauvelt A., Asada H., Klaus-Kovtun V., et al. Interleukin-15 mRNA is expressed by human keratinocytes Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. J. Invest. Dermatol. 1996, 106:1047-1052.
28. Bluman E.M., Bartynski K.J., Avalos B.R., Caligiuri M.A. Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines. J. Clin. Invest. 1996, 97:2722-2727.
29. Bonig H., Banning U., Hannen M., et al. Transforming growth factor-betal suppresses interleukin-15-mediated interferon-gamma production in human T lymphocytes. Scand. J. Immunol. 1999, 50:612-618.
30. Borger P., Kauffman H.F., Postma D.S., et al. Interleukin-15 differentially enhances the expression of interferon-gamma and interleukin-4 in activated human (CD4+) T lymphocytes. Immunology 1999, 96:207-214.
31. Bulanova E., Budagian V., Pohl T., et al. The IL-15R alpha chain signals through association with Syk in human B cells. J. Immunol. 2001, 167:6292-6302.
32. Bulfone-Paus S., Ungureanu D., Pohl T., et al. Interleukin-15 protects from lethal apoptosis in vivo. Nat. Med. 1997, 3:1124-1128.
33. Bulfone-Paus S., Durkop H., Paus R., et al. Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Cytokine 1997, 9:507-513.
34. Bulfone-Pau S.S., Bulanova E., Pohl T., et al. Death deflected, IL-15 inhibitts TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J. 1999, 13:1575-1585.
35. Burton J.D., Bamford R.N., Peters C., et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl Acad. Sci. USA 1994, 91:4935-4939.
36. Bykovskaia S.N., Buffo M., Zhang H., et al. The generation of human dendritic and NK cells from hemopoietic progenitors induced by interleukin-15. J. Leukoc. Biol. 1999, 66:659-666.
37. Canals A., Gasbarre L.C., Boyd P.C., et al. Cloning and expression of bovine interleukin-15, analysis and modulation of transcription by exogenous stimulation. J. Interferon Cytokine Res. 1997, 17:473-480.
38. Cao S., Black J.D., Troutt A.B., Rustum Y.M. Interleukin 15 offers selective protection from irinotecan-induced intestinal toxicity in a preclinical animal model. Cancer Res. 1998, 58:3270-3274.
39. Carayol G., Robin C., Bourhis J.H., et al. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Eur. J. Immunol. 1998, 28:1991-2002.
40. Carayol G., Giron-Michel J., Azzarone B., et al. Altered natural killer cell differentiation in CD34+progenitors from chronic myeloid leukemia patients. Oncogene 2000, 19:2758-2766.
41. Carbo N., Lopez-Soriano J., Costelli P., et al. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br. J. Cancer 2000, 83:526-531.
42. Carbo N., Lopez-Soriano J., Costelli P., et al. Interleukin-15 mediates reciprocal regulation of adipose and muscle mass, a potential role in body weight control. Biochim. Biophys. Acta 2001, 1526:17-24.
43. Caron G., Delneste Y., Aubry J.P., et al. Human NK cells constitutively express membrane TNF-alpha (mTNFalpha) and present mTNFalpha-dependent cytotoxic activity. Eur. J. Immunol. 1999, 29:3588-3595.
44. Carson W.E., Giri J.G., Lindemann M.J., et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 1994, 180:1395-1403.
45. Carson W.E., Ross M.E., Baiocchi R.A., et al. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Invest. 1995, 96:2578-2582.
46. Carson W.E., Fehniger T.A., Haldar S., et al. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J. Clin. Invest. 1997, 99:937-943.
47. Carson W., Caligiuri M.A. Interleukin-15 as a potential regulator of the innate immune response. Braz. J. Med. Bioo. Res. 1998, 31:1-9.
48. Cassatella M.A., McDonald P.P. Interleukin-15 and its impact on neutrophil function. Curr. Opin. Hematol. 2000, 7:174-177.
49. Chang K.H., Kim J.M., Yoo N.C., et al. Restoration of P-glycoprotein function is involved in the increase of natural killer activity with exogenous interleukin-15 in human immunodeficiency virus-infected individuals. Yonsei Med. J. 2000, 41:600-606.
50. Chang K.H., Kim J.M., Kim H.Y., et al. Spontaneous programmed cell death of peripheral blood mononuclear cells from HIV-infected persons is decreased with interleukin-15. Yonsei Med. J. 2000, 41:112-118.
51. Chen Y.M., Ting C.C., Peng J.W., et al. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion, interleukin-15 vs. interleukin-2. J. Interferon Cytokine Res. 2000, 20:31-39.
52. Chu C.L., Chen S.S., Wu T.S., et al. Differential effects of IL-2 and IL-15 on the death and survival of activated TCR gamma delta+ intestinal intraepithelial lymphocytes. J. Immunol. 1999, 162:1896-1903.
53. Constantinescu C.S., Grygar C., Kappos L., Leppert D. Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells. Cytokine 2001, 13:244-247.
54. Cosman D., Kumaki S., Ahdieh M., et al. Interleukin 15 and its receptor. Ciba Found. Symp. 1995, 195:221-229.
55. Cosman D., Kumaki S., Anderson D., et al. Interleukin 15. Biochem. Soc. Trans. 1997, 25:371-374.
56. D'Auria L., Bonifati C., Cordiali-Fei P., et al. Increased serum interleukin-15 levels in bullous skin diseases, correlation with disease intensity. Arch. Dermatol. Res. 1999, 291:354-356.
57. De Giovanni C., Nanni P., Sacchi A., et al. Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cells. Br. J. Cancer 1998, 78:1541-1546.
58. Demoulin J.B., Renauld J.C. Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol. Ther. 1998, 4:243-256.
59. Di Carlo E., Meazza R., Basso S., et al. Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice. J. Pathol. 2000, 191:193-201.
60. Dirksen U., Asadi-Moghaddam K., Fuhrer M., Burdach S. Defunct hematopoietic progenitor growth and heterogeneous immunological phenotypes in acquired aplastic anemia of childhood, identification of subsets with decreased hematopoietic progenitors and increased IL15 or IL10 production. Klin. Padiatr. 1998, 210:167-172.
61. DiSanto J.P. Cytokines, shared receptors, distinct functions. Curr. Biol. 1997, 7:R424-R426.
62. Dobbeling U., Dummer R., Laine E., et al. Interleukin-15 is an autocrine/paracrine vaability factor for cutaneous T-cell lymphoma cells. Blood 1998, 92:252-258.
63. Doherty T.M., Seder R.A., Sher A. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 1996, 156:735-741.
64. Dooms H., Van Belle T., Desmedt M., et al. Interleukin-15 redirects the outcome of a tolerizing T-cell stimulus from apoptosis to anergy. Blood 2000, 96:1006-1012.
65. Dubois S., Magrangeas F., Lehours P., et al. Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression. J. Biol. Chem. 1999, 274:26978-26984.
66. Ebert E.C. Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology 1998, 115:1439-1445.
67. Edelbaum D., Mohamadzadeh M., Bergstresser P.R., et al. Interleukin (IL)-15 promotes the growth of murine epidermal gamma delta T cells by a mechanism involving the beta- and gamma c-chains of the IL-2 receptor. J. Invest. Dermatol. 1995, 105:837-843.
68. Elloso M.M., van der Heyde H.C., Troutt A., et al. Human hamma delta T cell subset-proliferative response to malarial antigen in vitro depends on CD4+ T cells or cytokines that signal through components of the IL-2R. J. Immunol. 1996, 157:2096-2102.
69. Elloso M.M., Wallace M., Manning D.D., Weidanz W.P. The effects of interleukin-15 on human gammadelta T cell responses to Plasmodium falciparum in vitro. Immunol. Lett. 1998, 64:125-132.
70. Estess P., Nandi A., Mohamadzadeh M., Siegelman M.H. Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo. J. Exp. Med. 1999, 190:9-19.
71. Fawaz L.M., Sharif-Askari E., Menezes J. Upregulation of NK cytotoxic activity via IL-15 induction by different viruses, a comparative study. J. Immunol. 1999, 163:4473-4480.
72. Fehniger T.A., Suzuki K., Ponnappan A., et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J. Exp. Med. 2001, 193:219-231.
73. Gadina M., Stancato L.M., Bacon C.M., et al. Involvement of SHP-2 in multiple aspects of IL-2 signaling, evidence for a positive regulatory role. J. Immunol. 1998, 160:4657-4661.
74. Gadina M., Sudarshan C., Visconti R., et al. The docking molecule gab2 is induced by lymphocyte activation and is involved in signaling by interleukin-2 and interleukin-15 but not other common gamma chain-using cytokines. J. Biol. Chem. 2000, 275:26959-26966.
75. Gaggero A., Azzarone B., Andrei C., et al. Differential intracellular trafficking, secretion and endosomal localization of two IL-15 isoforms. Eur. J. Immunol. 1999, 29:1265-1274.
76. Gamero A.M., Ussery D., Reintgen D.S., et al. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res. 1995, 55:4988-4994.
77. Gilmour K.C., Fujii H., Cranston T., et al. Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency. Blood 2001, 98:877-879.
78. Girard D., Paquet M.E., Paquin R., Beaulieu A.D. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils, modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood 1996, 88:3176-3184.
79. Giri J.G., Anderson D.M., Kumaki S., et al. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukoc. Biol. 1995, 57:763-766.
80. Giri J.G., Kumaki S., Ahdieh M., et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 1995, 14:3654-3663.
81. Gosselin J., Tomolu A., Gallo R.C., Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 1999, 94:4210-4219.
82. Grabstein K.H., Eisenman J., Shanebeck K., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994, 264:965-968.
83. Graninger W.B., Steiner C.W., Graninger M.T., et al. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupuserythematosus. Cell Death Differ 2000, 7:966-972.
84. Gursel M., Gregoriadis G. Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo. Immunol. Lett. 1997, 55:161-165.
85. Han G.W., Iwatsuki K., Inoue M., et al. Interleukin-15 is not a constitutive cytokine in the epidermis, but is inducible in culture of inflammatory conditions. Acta. Derm. Venereol. 1999, 79:37-40.
86. Hanisch U.K., Lyons S.A., Prinz M., et al. Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity. J. Biol. Chem. 1997, 272:28853-28860.
87. Harada S., Yamamura M., Okamoto H., et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42:1508-1516.
88. Hasan M.S., Kallas E.G., Thomas E.K., et al. Effects of interleukin-15 on in vitro human T cell proliferation and activation. J. Interferon Cytokine Res. 2000, 20:119-123.
89. Hausmann M.J., Rogachev B., Weiler M., et al. Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth. Kidney Int. 2000, 57:476-486.
90. Hazama S., Noma T., Wang F., et al. Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo. Br. J. Cancer 1999, 80:1420-1426.
91. Heikkinen J., Mottonen M., Pulkki K., et al. Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of pre-eclampsia. Scand. J. Immunol. 2001, 53:310-314.
92. Hirose K., Suzuki H., Nishimura H., et al. Interleukin-15 may be responsible for early activation of intestinal intraepithelial lymphocytes after oral infection with Listeria monocytogenes in rats. Infect. Immun. 1998, 66:5677-5683.
93. Hjorth-Hansen H., Waage A., Borset M. Interleukin-15 blocks apoptosis and induces proliferation of the human myeloma cell line OH-2 and freshly isolated myeloma cells. Br. J. Haematol. 1999, 106:28-34.
94. Ishimitsu R., Nishimura H., Yajima T., et al. Overexpression of IL-15 in vivo enhances Tcl response, which inhibits allergic inflammation in a murine model of asthma. J. Immunol. 2001, 166:1991-2001.
95. Johnston J.A., Bacon C.M., Finbloom D.S., et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc. Natl Acad. Sci. USA 1995, 92:8705-8709.
96. Jonuleit H., Wiedemann K., Muller G., et al. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells, a role for IL-15 in attraction of T cells. J. Immunol. 1997, 158:2610-2615.
97. Kacani L., Sprinzl G.M., Erdei A., Dierich M.P. Interleukin-15 enhances HIV-1-driven polyclonal B-cell response in vitro. Exp. Clin. Immunogenet. 1999, 16:162-172.
98. Kakumu S., Okumura A., Ishikawa T., et al. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin. Exp. Immunol. 1997, 109:458-463.
99. Karnitz L.M., Abraham R.T. Cytokine receptor signaling mechanisms. Curr. Opin. Immunol. 1995, 7:320-326.
100. Kayagaki N., Yamaguchi N., Nakayama M., et al. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 1999, 163:1906-1913.
101. Kebelmann-Betzing C., Korner G., Badiali L., et al. Characterization of cytokine growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor all. Cytokine 2001, 13:39-50.
102. Kennedy M.K., Glaccum M., Brown S.N., et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 2000, 191:771-780.
103. Kimura K., Nishimura H., Matsuzaki T. Synergistic effect of interleukin-15 and interleukin-12 on antitumor activity in a murine malignant pleurisy model. Cancer Immunol. Immunother. 2000, 49:71-77.
104. Kirman I., Nielsen O.H. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 1996, 91:1789-1794.
105. Kirman I., Vainer B., Nielsen O.H. Interleukin-15 and its role in chronic inflammatory. Inflamm. Res. 1998, 47:285-289.
106. Kitaya K., Yasuda J., Yagi I., et al. IL-15 expression at human endometrium and decidua. Biol. Reprod. 2000, 63:683-687.
107. Kivisakk P., Matusevicius D., He B., et al. IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clin. Exp. Immunol. 1998, 111:193-197.
108. Klimiuk P.A., Yang H., Goronzy J.J., Weyand C.M. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin. Immunol. 1999, 90:65-78.
109. Kobayashi H., Carrasquillo J.A., Paik C.H., et al. Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15. Cancer Res. 2000, 60:3577-3583.
110. Krause H., Jandrig B., Wernicke C., et al. Genomic structure and chromosomal localization of the human interleukin 15 gene (IL-15). Cytokine 1996, 8:667-674.
111. Ku C.C., Murakami M., Sakamoto A., et al. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000, 288:675-678.
112. Kumaki N., Anderson D.M., Cosman D., Kumaki S. Expression of interleukin-15 and its receptor by human fetal retinal pigment epithelial cells. Curr. Eye Res. 1996, 15:876-882.
113. Kumaki S., Armitage R., Ahdieh M., et al. Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells. Eur. J. Immunol. 1996, 26:1235-1239.
114. Kuniyoshi J.S., Kuniyoshi C.J., Lim A.M., et al. Dendritic cell secretion of IL-15 is induced by recombinant huCD40LT and augments the stimulation of antigen-specific cytolytic T cells. Cell Immunol. 1999, 193:48-58.
115. Kurys G., Tagaya Y., Bamford R., et al. The long signal peptide isoform and its alternative processing direct the intracellular trafficking of interleukin-15. J. Biol. Chem. 2000, 275:30653-30659.
116. Lasek W., Golab J., Maslinski W., et al. Subtherapeutic doses of interleukin-15 augment the antitumor effect of interleukin-12 in a B16F10 melanoma model in mice. Eur. Cytokine Netw. 1999, 10:345-356.
117. Leclercq G., Debacker V., de Smedt M., Plum J. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J. Exp. Med. 1996, 184:325-336.
118. Lee Y.B., Satoh J., Walker D.G., Kim S.U. Interleukin-15 gene expression in human astrocytes and microglia in culture. Neuroreport 1996, 7:1062-1066.
119. Leroy S., Dubois S., Tenaud I., et al. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br. J. Dermatol. 2001, 144:1016-1023.
120. Lewko W.M., Smith T.L., Bowman D.J., et al. Interleukin-15 and the growth of tumor derived activated T-cells. Cancer Biother. 1995, 10:13-20.
121. Li X.C., Demirci G., Ferrari-Lacraz S., et al. IL-15 and IL-2, a matter of life and death for T cells in vivo. Nat. Med. 2001, 7:114-118.
122. Lin S.J., Roberts R.L., Ank B.J., et al. Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection. J. Clin. Immunol. 1998, 18:335-345.
123. Lindner G., Ruckert R., Bulfone-Paus S., Paus R. Inhibition of chemotherapy-induced keratinocyte apoptosis in vivo by an interleukin-15-IgG fusion protein. J. Invest. Dermatol. 1998, 110:457-458.
124. Lissoni P., Rovelli F., Mandala M., Barni S. Blood concentrations of interleukin-15 in cancer patients and their variations during interleukin-2 immunotherapy, preliminary considerations. Int. J. Biol. Markers 1998, 13:169-171.
125. Liu T., Nishimura H., Matsuguchi T., Yoshikai Y. Differences in interleukin-12 and -15 production by dendritic cells at the early stage of Listeria monocytogenes infection between BALB/c and C57 BL/6 mice. Cell Immunol. 2000, 202:31-40.
126. Liu Z., Geboes K., Colpaert S., et al. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J. Immunol. 2000, 164:3608-3615.
127. Lodolce J.P., Boone D.L., Chai S., et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998, 9:669-676.
128. Lollini P.L., Palmieri G., De Giovanni C., et al. Expression of interleukin 15 (IL-15) in human rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma. Int. J. Cancer 1997, 71:732-736.
129. Lucey D.R., Pinto L.A., Bethke F.R., et al. In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin. Diagn. Lab. Immunol. 1997, 4:43-48.
130. Lugering N., Kucharzik T., Maaser C., et al. Interleukin-15 strongly inhibits interleukin-8 and monocyte chemoattractant protein-1 production in human colonic epithelial cells. Immunology 1999, 98:504-509.
131. Maeurer M., Seliger B., Trinder P., et al. Interleukin-15 in mycobacterial infection of antigen-presenting cells. Scand. J. Immunol. 1999, 50:280-288.
132. Maeurer M.J., Trinder P., Hommel G., et al. Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice. Infect. Immun. 2000, 68:2962-2970.
133. Maiuri L., Ciacci C., Auricchio S., et al. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 2000, 119:996-1006.
134. Mastroianni C.M., d'Ettorre G., Forcina G., et al. Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. Blood 2000, 96:1979-1984.
135. Masuda A., Matsuguchi T., Yamaki K., et al. Interleukin-15 induces rapid tyrosine phosphorylation of STAT6 and the expression of interleukin-4 in mouse mast cells. J. Biol. Chem. 2000, 275:29331-29337.
136. Masuda A., Matsuguchi T., Yamaki K., et al. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression. J. Biol. Chem. 2001, 276:26107-26113.
137. Matsumoto K., Kanmatsuse K. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome. Clin. Nephrol. 1999, 52:10-18.
138. Mattei F., Schiavoni G., Belardelli F., Tough D.F. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 2001, 167:1179-1187.
139. McDonald P.P., Russo M.P., Ferrini S., Cassatella M.A. Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils. Blood 1998, 92:4828-4835.
140. McInnes I.B., al-Mughales J., Field M., et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat. Med. 1996, 2:175-182.
141. McInnes I.B., Leung B.P., Sturrock R.D., et al. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in eheumatoid arthritis. Nat. Med. 1997, 3:189-195.
142. Meazza R., Gaggero A., Neglia F., et al. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion, role of different signal peptides. Eur. J. Immunol. 1997, 27:1049-1054.
143. Meijssen M.A., Brandwein S.L., Reinecker H.C., et al. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. Am. J. Physiol. 1998, 274:G472-G479.
144. Merendino R.A., Arena A., Gangemi S., et al. In vitro effect of lithium chloride on interleukin-15 production by monocytes from IL-breast cancer patients. J. Chemother. 2000, 12:252-257.
145. Mohamadzadeh M., McGuire M.J., Dougherty I., Cruz P.D. Interleukin-15 expression by human endothelial cells, up-regulation by ultraviolet B and psoralen plus ultraviolet A treatment. Photodermatol. Photoimmunol. Photomed. 1996, 12:17-21.
146. Mohamadzadeh M., Berard F., Essert G., et al. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 2001, 194:1013-1020.
147. Mori N., Yamada Y., Tomonaga M., et al. Interleukin-15 stimulates the proliferation of peripheral blood leukemic cells from adult T-cell leukemia patients. Eur. J. Haematol. 1998, 61:278-279.
148. Mottonen M., Isomaki P., Luukkainen R., et al. Interleukin-15 up-regulates the expression of CD154 on synovial fluid T cells. Immunology 2000, 100:238-244.
149. Mrozek E., Anderson P., Caligiuri M.A. Role of interleukin-15 in the development of human CD56+natural killer cells from CD34+ hematopoietic progenitor cells. Blood 1996, 87:2632-2640.
150. Munger W., DeJoy S.Q., Jeyasselan R., et al. Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor, comparison with interleukin-2. Cell Immunol. 1995, 165:289-293.
151. Musso T., Calosso L., Zucca M., et al. Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclea cells. Infect. Immun. 1998, 66:2640-2647.
152. Musso T., Calosso L., Zucca M., et al. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gammas-upregulated interleukin-15. Blood 1999, 93:3531-3539.
153. Naora H., Gougeon M. Activation, survival and apoptosis of CD45RO+and CD45RO-T cells of human immunodeficiency virus-infected individuals, effects of interleukin-15 and comparison with interleukin-2. Immunology 1999, 97:181-187.
154. Naora H., Gougeon M.L. Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukins-15. Immunol. Lett. 1999, 68:359-367.
155. Nieto M., del Pozo M.A., Sanchez-Madrid F. Interleukin-15 induces adhesion receptor redistribution in T lymphocytes. Eur. J. Immunol. 1996, 26:1302-1307.
156. Nishimura H., Washizu J., Nakamura N., et al. Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA. J. Immunol. 1998, 160:936-942.
157. Nishimura H., Yajima T., Naiki Y., et al. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J. Exp. Med. 2000, 191:157-170.
158. Ogata Y., Kukita A., Kukita T., et al. A novel role of IL-15 in the development of osteoclasts, inability to replace its activity with IL-2. J. Immunol. 1999, 162:2754-2760.
159. Ohteki T., Suzue K., Maki C., et al. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immunol. 2001, 2:1138-1143.
160. Okada H., Nakajima T., Sanezumi M., et al. Progesterone enhances interleukin-15 production in human endometrial stromal cells in vitro. J. Clin. Endocrinol. Metab. 2000, 85:4765-4770.
161. Okada S., Okada H., Sanezumi M., et al. Expression of interleukin-15 in human endometrium and decidua. Mol. Hum. Reprod. 2000, 6:75-80.
162. Onu A., Pohl T., Krause H., Bulfone-Paus S. Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J. Immunol. 1997, 158:255-262.
163. Oppenheimer-Marks N., Brezinschek R.I., Mohamadzadeh M., et al. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo. J. Clin. Invest. 1998, 101:1261-1272.
164. Orteu C.H., Rustin M.H., O'Toole E., et al. The inhibition of cutaneous T cell apoptosis may prevent resolution of inflammation in atopic eczema. Clin. Exp. Immunol. 2000, 122:150-156.
165. Ozaki K., Kikly K., Michalovich D., et al. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc. Natl Acad. Sci. USA 2000, 97:11439-11444.
166. Park Y.B., Kim D.S., Lee W.K., et al. Elevated serum interleukin-15 levels in systemic lupus erythematosus. Yonsei Med. J. 1999, 40:343-348.
167. Parrish-Novak J., Dillon S.R., Nelson A., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000, 408:57-63.
168. Pashenkov M., Mustafa M., Kivisakk P., Link H. Levels of interleukin-15-expressing blood mononuclear cells are elevated in multiple sclerosis. Scand. J. Immunol. 1999, 50:302-308.
169. Pereno R., Gaggero A., Scudeletti M., et al. IL-15/IL-15R alpha intracellular trafficking in human cells and protection from apoptosis. Ann. NY Acad. Sci. 1999, 876:236-245.
170. Perera L.P. Interleukin 15, its role in inflammation and immunity. Arch. Immunol. Ther. Exp. 2000, 48:457-464.
171. Perera L.P., Goldman C.K., Waldmann T.A. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J. Immunol. 1999, 162:2606-2612.
172. Pirtskhalaishvili G., Shurin G.V., Esche C., et al. Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br. J. Cancer 2000, 83:506-513.
173. Prinz M., Hanisch U.K., Kettenmann H., Kirchhoff F. Alternative splicing of mouse IL-15 is due to the use of an internal splice site in exon 5. Brain Res. Mol. Brain Res. 1998, 63:155-162.
174. Quaranta M.G., Camponeschi B., Straface E., et al. Induction of interleukin-15 production by HIV-1 nef protein, a role in the proliferation of uninfected cells. Exp. Cell Res. 1999, 250:112-121.
175. Quinn L.S., Haugk K.L., Grabstein K.H. Interleukin-15, a novel anabolic cytokine for skeletal muscle. Endocrinology 1995, 136:3669-3672.
176. Quinn L.S., Haugk K.L., Damon S.E. Interleukin-15 stimulates C2 skeletal myoblast differentiation. Biochem. Biophys. Res. Commun. 1997, 239:6-10.
177. Rappl G., Kapsokefalou A., Heuser C., et al. Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor-alpha. J. Invest. Dermatol. 2001, 116:102-109.
178. Raulet D.H. Development and tolerance of natural killer cells. Curr. Opin. Immunol. 1999, 11:129-134.
179. Reinecker H.C., MacDermott R.P., Mirau S., et al. Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology 1996, 111:1706-1713.
180. Ruchatz H., Leung B.P., Wei X.Q., et al. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis, a role for IL-15 in development of antigen-induced immunopathology. J. Immunol. 1998, 160:5654-5660.
181. Ruckert R., Asadullah K., Seifert M., et al. Inhibition of keratinocyte apoptosis by IL-15, a new parameter in the pathogenesis of psoriasis?. J. Immunol. 2000, 165:2240-2250.
182. Sakai T., Kusugami K., Nishimura H., et al. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 1998, 114:1237-1243.
183. Sancho D., Yanez-Mo M., Tejedor R., Sanchez-Madrid F. Activation of peripheral blood T cell by interaction and migration through endothelium, role of lymphocyte function antigens-1/intercellular adhesion molecule-1 and interleukin-15. Blood 1999, 93:886-896.
184. Satoh J., Kurohara K., Yukitake M., Kuroda Y. Interleukin-15, a T-cell growth factor, is expressed in human neural cell lines and tissues. J. Neurol. Sci. 1998, 155:170-177.
185. Searle R.F., Bromage S.J., Palmer J., et al. Human amniotic fluid lacks interleukin-2 and interleukin-15 but can interact with the beta-chain of the interleukin-2 receptor. Immunology 2000, 99:411-417.
186. Sebbag M., Parry S.L., Brennan F.M., Feldmann M. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10, possible relevance to pathophysiology of rheumatoid arthritis. Eur. J. Immunol. 1997, 27:624-632.
187. Shurin M.R., Lu L., Kalinski P., Stewart-Akers A.M., Lotze M.T. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin. Immunopathol. 1999, 21:339-359.
188. Smith X.G., Bolton E.M., Ruchatz H., et al. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. J. Immunol. 2000, 165:3444-3450.
189. Stevens A.C., Matthews J., Andres P., et al. Interleukin-15 signals T84 colonic epithelial cells in the absence of the interleukin-2 receptor beta-chain. Am. J. Physiol. 1997, 272:G1201-G1208.
190. Stoeck M., Schafer M., Hofmann H.P., Gekeler V. Dexamethasone and cyclosporin A do not inhibit interleukin-15 expression in the human lung carcinoma cell line A549. Eur. Cytokine Netw. 2000, 11:414-419.
191. Suzuki K., Nakazato H., Matsui H., et al. NK cellmediated anti-tumor immune response to human prostate cancer cell, PC-3, immunogene therapy using a highly secretable form of interleukin-15 gene transfer. J. Leukoc. Biol. 2001, 69:531-537.
192. Tagaya Y., Bamford R.N., DeFilippis A.P., Waldmann T.A. IL-15, a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996, 4:329-336.
193. Tagaya Y., Burton J.D., Miyamoto Y., Waldmann T.A. Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells. EMBO J. 1996, 15:4928-4939.
194. Tagaya Y., Kurys G., Thies T.A., et al. Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc. Natl Acad. Sci. USA 1997, 94:14444-14449.
195. Takeuchi E., Yanagawa H., Suzuki Y., et al. Interleukins (IL-)15 has less activity than IL-2 to promote type 2 cytokine predominance in tumour-associated mononuclear cells from lung cancer patients. Cytokine 2001, 13:119-123.
196. Tasaki K., Yoshida Y., Miyauchi M., et al. Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumors effects in immunocompetent and immunocompromised hosts. Cancer Gene. Ther. 2000, 7:255-261.
197. Thurkow E.W., van der Heijden I.M., Breedveld F.C., et al. Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J. Pathol. 1997, 181:444-450.
198. Tinhofer I., Marschitz I., Henn T., et al. Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma. Blood 2000, 95:610-618.
199. Tourkova I.L., Yurkovetsky Z.R., Gambotto A., et al. Increased function and survival of IL-15-transfected human dendritic cells are mediated by increased up-regulation of IL-15Rα and Bcl-2. J. Leuk. Biol. 2002, 72:1037-1045.
200. Trentin L., Cerutti A., Zambello R., et al. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders. Blood 1996, 87:3327-3335.
201. Trentin L., Zambello R., Facco M., et al. Interleukin-15, a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. Leuk. Lymphoma 1997, 27:35-42.
202. Trinder P., Seitzer U., Gerdes J., et al. Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. Int. J. Oncol. 1999, 14:23-31.
203. Tsunobuchi H., Nishimura H., Goshima F., et al. A protective role of interleukin-15 in a mouses model for systemic infection with herpes simplex virus. Virology 2000, 275:57-66.
204. Vainer B., Nielsen O.H., Hendel J., et al. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine 2000, 12:1531-1536.
205. Vazquez N., Walsh T.J., Friedman D., et al. Interleukin-15 augments superoxide production and microbicidal activity of human monocytes against Candida albicans. Infect. Immun. 1998, 66:145-150.
206. Vosshenrich C.A., Di Santo J.P. Cytokines, IL-21 joins the gamma(c)-dependent network?. Curr. Biol. 2001, 11:R175-R177.
207. Waldmann T., Tagaya Y., Bamford R. Interleukin-2, interleukin-15, and their receptors. Int. Rev. Immunol. 1998, 16:205-226.
208. Waldmann T.A., Dubois S., Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes, implications for immunotherapy. Immunity 2001, 14:105-110.
209. Wei X., Orchardson M., Gracie J.A., et al. The sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo. J. Immunol. 2001, 167:277-282.
210. Weiler M., Rogashev B., Einbinder T., et al. Interleukin-15, a leukocyte activator and growth factor, is produced by cortical tubular epithelial cells. J. Am. Soc. Nephrol. 1998, 9:1194-1201.
211. Weiler M., Kachko L., Chaimovitz C., et al. CD40 ligation enhances IL-15 production by tubular epithelial cells. J. Am. Soc. Nephrol. 2001, 12:80-87.
212. Yamada Y., Kamihira S. Pathological roles of interleukins-15 in adult T-cell leukemia. Leuk. Lymphoma 1999, 35:37-45.
213. Yoshikai Y., Nishimura H. The role of interleukin 15 in mounting an immune response against microbial infections. Microbes Infect. 2000, 2:381-389.
214. Zhang X., Sun S., Hwang I., et al. Potent and selective stimulation of memory-phenotype CD8+T cells in vivo by IL-15. Immunity 1998, 8:591-599.